Harpoon therapeutics, inc. (HARP)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Dec'17
Assets
Current assets
Cash and cash equivalents

36,168

88,736

56,764

52,094

95,926

89,493

29,423

Short-term marketable securities

86,929

59,337

64,463

81,790

42,646

-

-

Prepaid expenses and other current assets

5,600

2,544

1,764

3,438

2,081

730

224

Total current assets

128,697

150,617

122,991

137,322

140,653

90,223

29,647

Property and equipment, net

10,976

11,383

11,770

11,773

5,502

2,998

2,087

Long-term marketable securities

15,143

7,056

-

-

8,978

-

-

Operating lease right-of-use asset

6,917

7,015

7,106

7,454

8,116

-

-

Tenant improvement allowance receivable

-

-

-

-

3,078

5,784

-

Other assets

763

533

521

467

605

3,575

138

Total assets

162,496

176,604

142,388

157,016

166,932

102,580

31,872

Liabilities and stockholders' equity
Current liabilities
Accounts payable

1,545

2,594

3,900

4,519

3,411

4,357

1,174

Accrued liabilities

7,131

7,495

7,719

4,876

3,664

3,341

1,492

Deferred revenue, current

13,874

11,207

4,080

4,250

4,250

4,250

4,250

Operating lease liabilities, current

1,264

1,217

987

862

572

-

-

Total current liabilities

23,814

22,513

16,686

14,507

11,897

11,948

6,916

Deferred revenue, noncurrent

41,994

46,144

4,420

5,667

6,729

7,792

12,042

Operating lease liabilities, net of current portion

13,394

13,727

14,051

14,369

14,712

-

-

Other long-term liabilities

-

-

-

-

-

6,742

16

Total liabilities

79,202

82,384

35,157

34,543

33,338

26,482

18,974

Convertible preferred stock, $0.0001 par value; 10,000,000 shares and 82,000,000 shares authorized at December 31, 2019 and 2018, respectively; no shares and 16,618,448 shares issued and outstanding as of December 31, 2019 and 2018, respectively

-

-

-

-

-

129,577

39,841

Stockholders' equity
Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2020 and December 31, 2019; 24,938,574 shares and 24,850,064 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

1

1

Additional paid-in capital

213,535

212,339

211,038

210,347

209,735

9,111

8,309

Accumulated other comprehensive income

471

41

85

110

26

-

-

Note receivable from stockholder

-

-

-

-

-

-

28

Accumulated deficit

-130,715

-118,163

-103,895

-87,987

-76,170

-62,591

-35,225

Total stockholders' equity

83,294

94,220

107,231

122,473

133,594

-53,479

-26,943

Total liabilities and stockholders' equity

162,496

176,604

142,388

157,016

166,932

102,580

31,872